ClinConnect ClinConnect Logo
Search / Trial NCT05127265

Pervasive Sensing and AI in Intelligent ICU

Launched by UNIVERSITY OF FLORIDA · Nov 18, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Critical Illness Pain Delirium Confusion Patient Acuity Icu Acute Illness

ClinConnect Summary

This clinical trial is exploring a new way to assess the condition of patients in the Intensive Care Unit (ICU) using advanced technology. The researchers aim to develop a smart system that can observe and understand patients' facial expressions, movements, and overall physical state without relying solely on busy nurses. By using special sensors and artificial intelligence, the goal is to better recognize signs of pain, emotional distress, and changes in physical function. This could help doctors provide more accurate and timely care for critically ill patients.

To participate in this trial, you must be at least 18 years old and currently admitted to the UF Health Shands Gainesville ICU, with a plan to stay there for at least 24 hours. Unfortunately, if you are under 18, currently on isolation precautions, or expected to leave the ICU within 24 hours, you would not be eligible. If you choose to join, you will be part of an effort to improve how healthcare providers monitor and respond to patient needs, potentially leading to better outcomes for everyone in the ICU.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • aged 18 or older
  • admitted to UF Health Shands Gainesville ICU ward
  • expected to remain in ICU ward for at least 24 hours at time of screening
  • Exclusion Criteria:
  • under the age of 18
  • on any contact/isolation precautions
  • expected to transfer or discharge from the ICU in 24 hours or less
  • unable to provide self-consent or has no available proxy/LAR

About University Of Florida

The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.

Locations

Gainesville, Florida, United States

Patients applied

0 patients applied

Trial Officials

Azra Bihorac, MD, MS

Principal Investigator

University of Florida

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials